Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
نویسندگان
چکیده
منابع مشابه
Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.
Ovarian cancer remains the fourth leading cause of cancer death in women in France. It is all too often diagnosed at an advanced stage with peritoneal carcinomatosis (PC), but remains confined to the peritoneal cavity throughout much of its natural history. Because of cellular selection pressure over time, most tumor recurrences eventually develop resistance to systemic platinum. Options for sa...
متن کاملHyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?
women despite the fact that, paradoxically, it has innate characteristics which should facilitate effective treatment: it begins, and frequently remains, confined within the peritoneal cavity for much of its natural history (apart, most notably) from retroperitoneal lymph node involvement, it is relatively 'non-invasive' and thus amenable to surgical resection, and it responds well to initial c...
متن کاملHyperthermic Intraperitoneal Chemotherapy
Selected patients with peritoneal surface malignancies benefit from a radical therapeutic approach consisting of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy (PIC), whichmay be complemented by systemic chemotherapy. Numerous studies have shown the efficacy of this strategy, which has led to survival results unknown to date, even in the era of last-generation ch...
متن کاملHyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.
OBJECTIVE To assess the feasibility and efficacy of cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) without adjuvant chemotherapy for relapsed or persistent advanced ovarian cancer. METHODS This observational study included stage IIIC ovarian cancer patients due to undergo CRS (interval debulking or recurrent surgery) followed by HIPEC with oxaliplati...
متن کاملIntraperitoneal chemotherapy for ovarian cancer.
Vol. 39, No. 4, July 2012 • Oncology Nursing Forum O varian cancer remains an uncommon cancer compared to other female malignancies, such as breast, lung, and colon cancer. However, ovarian cancer is the leading cause of death among all gynecologic malignancies and the second most prevalent of the reproductive cancers (Siegel, Naishadham, & Jemal, 2012). According to the National Comprehensive ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obstetrical & Gynecological Survey
سال: 2018
ISSN: 1533-9866,0029-7828
DOI: 10.1097/01.ogx.0000532155.55081.57